Monday, July 24, 2006

F.D.A. TO REVISE CONFLICT RULES --
The Food and Drug Administration is expected to announce Monday an effort to write guidelines detailing the kind of industry ties that are permitted for those who serve on its powerful advisory boards.

The agency is hoping the move will appease some of its critics who have complained for years that those who sit on its boards often have such deep financial ties to drug makers that their advice is tainted. Advisory boards recommend drugs for approval, and their votes can have enormous influence on drug company stock prices.